Evidence map›Paper›PMID 36248312›Full record

ArticleAdvanced materials interfaces2022

A Genetically Engineered Biofilm Material for SARS-CoV-2 Capturing and Isolation.

Gökçe Özkul, Ebru Şahin Kehribar, Recep Erdem Ahan, İlkay Çisil Köksaldı, Aykut Özkul, Bedia Dinç, Sibel Aydoğan, Urartu Özgür Şafak Şeker

Abstract read
In one paragraph

Article in Advanced materials interfaces, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gökçe ÖzkulUNAM - Institute of Materials Science and Nanotechnology Bilkent University Ankara 06800 Turkey.
Ebru Şahin KehribarUNAM - Institute of Materials Science and Nanotechnology Bilkent University Ankara 06800 Turkey.
Recep Erdem AhanUNAM - Institute of Materials Science and Nanotechnology Bilkent University Ankara 06800 Turkey.
İlkay Çisil KöksaldıUNAM - Institute of Materials Science and Nanotechnology Bilkent University Ankara 06800 Turkey.
Aykut ÖzkulDepartment of Virology Faculty of Veterinary Medicine Ankara University Dışkapı Ankara 06110 Turkey.
Bedia DinçMedical Microbiology Laboratory and Department of Clinical Microbiology and Infectious Diseases Ankara Bilkent City Hospital Health Sciences University Ankara 06800 Turkey.
Sibel AydoğanMedical Microbiology Laboratory and Department of Clinical Microbiology and Infectious Diseases Ankara Bilkent City Hospital Health Sciences University Ankara 06800 Turkey.
Urartu Özgür Şafak ŞekerUNAM - Institute of Materials Science and Nanotechnology Bilkent University Ankara 06800 Turkey.ORCID https://orcid.org/0000-0002-5272-1876

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuously infecting people all around the world since its outbreak in 2019. Studies for numerous infection detection strategies are continuing. The sensitivity of detection methods is crucial to separate people with mild infections from people who are asymptomatic. In this sense, a strategy that would help to capture and isolate the SARS-CoV-2 virus prior to tests can be effective and beneficial. To this extent, genetically engineered biomaterials grounding from the biofilm protein of

Indexed as

concentratinggenetically engineered biomaterialsSARS‐CoV‐2virus capturing

Identifiers

PMID36248312
PMCPMC9538133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.